Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Inflammation
Erschienen in: Inflammation 5/2018

11.07.2018 | ORIGINAL ARTICLE

Progranulin Is Positively Associated with Intervertebral Disc Degeneration by Interaction with IL-10 and IL-17 Through TNF Pathways

verfasst von: Shaoyi Wang, Jianlu Wei, Yuchen Fan, Hong Ding, Huichao Tian, Xiaocong Zhou, Lei Cheng

Erschienen in: Inflammation | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Progranulin (PGRN) is a widely expressed growth factor that effectively inhibits tumor necrosis factor α (TNFα)-mediated inflammatory response. TNFα is involved in intervertebral disc degeneration (IDD) and plays a key role. This study aims to determine the role of PGRN in the intervertebral disc degeneration process. We collected intervertebral discs (IVDs) from humans and mice with different genetic backgrounds. We examined the expression of PGRN in IVD tissues by immunohistochemistry staining and Western blotting assay. We examined the peripheral serum level of PGRN by ELISA assay. Murine IVD tissue samples were taken to undergo safranin O, HE, and immunohistochemistry staining. Primary human nucleus pulposus cells were used for ELISA and RT-PCR assays. PGRN as well as interlukin-10 (IL-10) and interlukin-17 (IL-17) expressions were elevated in degenerative discs and peripheral blood sera. Loss of PGRN led to accelerated disc degeneration in the animal model, along with decreased expression of IL-10 and increased expression of IL-17. Additionally, the PGRN level was positively related to levels of IL-10 and IL-17. In vitro study suggested that PGRN protected against disc degeneration by inducing IL-10 and reducing IL-17. PGRN is associated with intervertebral disc degeneration through interfering with IL-10 and IL-17; thus, PGRN could be an interesting biomarker for diagnosis and a potential treatment target.
Literatur
1.
Andersson, G.B., H.S. An, Oegema TR Jr, and L.A. Setton. 2006. Intervertebral disc degeneration. Summary of an AAOS/NIH/ORS workshop, September 2005. The Journal of Bone and Joint Surgery. American Volume 88 (4): 895–899.PubMed
2.
Gautschi, O.P., M.V. Corniola, N.R. Smoll, H. Joswig, K. Schaller, G. Hildebrandt, and M.N. Stienen. 2016. Sex differences in subjective and objective measures of pain, functional impairment, and health-related quality of life in patients with lumbar degenerative disc disease. Pain 157 (5): 1065–1071.CrossRefPubMed
3.
Molinos, M., C.R. Almeida, J. Caldeira, C. Cunha, R.M. Goncalves, and M.A. Barbosa. 2015. Inflammation in intervertebral disc degeneration and regeneration. Journal of the Royal Society, Interface 12 (104): 20141191.CrossRefPubMedPubMedCentral
4.
Feng, C., H. Liu, M. Yang, Y. Zhang, B. Huang, and Y. Zhou. 2016. Disc cell senescence in intervertebral disc degeneration: Causes and molecular pathways. Cell Cycle 15 (13): 1674–1684.CrossRefPubMedPubMedCentral
5.
Podichetty, V.K. 2007. The aging spine: The role of inflammatory mediators in intervertebral disc degeneration. Cellular and Molecular Biology (Noisy-le-Grand, France) 53 (5): 4–18.
6.
Andrade, P., et al. 2011. Tumor necrosis factor-alpha levels correlate with postoperative pain severity in lumbar disc hernia patients: opposite clinical effects between tumor necrosis factor receptor 1 and 2. Pain 152 (11): 2645–2652.CrossRefPubMed
7.
Shamji, M.F., L.A. Setton, W. Jarvis, S. So, J. Chen, L. Jing, R. Bullock, R.E. Isaacs, C. Brown, and W.J. Richardson. 2010. Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis and Rheumatism 62 (7): 1974–1982.PubMedPubMedCentral
8.
Phillips, K.L., et al. 2015. Potential roles of cytokines and chemokines in human intervertebral disc degeneration: Interleukin-1 is a master regulator of catabolic processes. Osteoarthritis and Cartilage 23 (7): 1165–1177.CrossRefPubMed
9.
Wei, J., C.J. Liu, and Z. Li. 2014. ADAMTS-18: A metalloproteinase with multiple functions. Frontiers in Bioscience (Landmark Edition) 19: 1456–1467.CrossRef
10.
Bertram, H., A. Nerlich, G. Omlor, F. Geiger, G. Zimmermann, and J. Fellenberg. 2009. Expression of TRAIL and the death receptors DR4 and DR5 correlates with progression of degeneration in human intervertebral disks. Modern Pathology 22 (7): 895–905.CrossRefPubMed
11.
Hoyland, J.A., C. Le Maitre, and A.J. Freemont. 2008. Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology (Oxford) 47 (6): 809–814.CrossRef
12.
Wang, H., M. Schiltenwolf, and M. Buchner. 2008. The role of TNF-alpha in patients with chronic low back pain-a prospective comparative longitudinal study. The Clinical Journal of Pain 24 (3): 273–278.CrossRefPubMed
13.
Ortiz, L.A., et al. 2001. Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis. American Journal of Respiratory and Critical Care Medicine 163 (1): 244–252.CrossRefPubMed
14.
Zhu, J., C. Nathan, W. Jin, D. Sim, G.S. Ashcroft, S.M. Wahl, L. Lacomis, H. Erdjument-Bromage, P. Tempst, C.D. Wright, and A. Ding. 2002. Conversion of proepithelin to epithelins: Roles of SLPI and elastase in host defense and wound repair. Cell 111 (6): 867–878.CrossRefPubMed
15.
He, Z., C.H.P. Ong, J. Halper, and A. Bateman. 2003. Progranulin is a mediator of the wound response. Nature Medicine 9 (2): 225–229.CrossRefPubMed
16.
Martens, L.H., J. Zhang, S.J. Barmada, P. Zhou, S. Kamiya, B. Sun, S.W. Min, L. Gan, S. Finkbeiner, E.J. Huang, and R.V. Farese Jr. 2012. Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. The Journal of Clinical Investigation 122 (11): 3955–3959.CrossRefPubMedPubMedCentral
17.
Tang, W., Y. Lu, Q.Y. Tian, Y. Zhang, F.J. Guo, G.Y. Liu, N.M. Syed, Y. Lai, E.A. Lin, L. Kong, J. Su, F. Yin, A.H. Ding, A. Zanin-Zhorov, M.L. Dustin, J. Tao, J. Craft, Z. Yin, J.Q. Feng, S.B. Abramson, X.P. Yu, and C.J. Liu. 2011. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332 (6028): 478–484.CrossRefPubMedPubMedCentral
18.
Jian, J., S. Zhao, Q. Tian, E. Gonzalez-Gugel, J.J. Mundra, S.M.Z. Uddin, B. Liu, B. Richbourgh, R. Brunetti, and C.J. Liu. 2013. Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains. FEBS Letters 587 (21): 3428–3436.CrossRefPubMed
19.
Li, M., Y. Liu, F. Xia, Z. Wu, L. Deng, R. Jiang, and F.J. Guo. 2014. Progranulin is required for proper ER stress response and inhibits ER stress-mediated apoptosis through TNFR2. Cellular Signalling 26 (7): 1539–1548.CrossRefPubMed
20.
Yang, X.D., and S.C. Sun. 2015. Targeting signaling factors for degradation, an emerging mechanism for TRAF functions. Immunological Reviews 266 (1): 56–71.CrossRefPubMedPubMedCentral
21.
22.
Yang, F., V.Y.L. Leung, K.D.K. Luk, D. Chan, and K.M.C. Cheung. 2009. Injury-induced sequential transformation of notochordal nucleus pulposus to chondrogenic and fibrocartilaginous phenotype in the mouse. The Journal of Pathology 218 (1): 113–121.CrossRefPubMed
23.
Wei, J.L., W. Fu, A. Hettinghouse, W.J. He, K.E. Lipson, and C.J. Liu. 2018. ADAMTS-12 protects against inflammatory arthritis through interacting with and inactivating proinflammatory CTGF. Arthritis & Rhematology. https://​doi.​org/​10.​1002/​art.​40552
24.
Weber, M.S., T. Prod'homme, S. Youssef, S.E. Dunn, C.D. Rundle, L. Lee, J.C. Patarroyo, O. Stüve, R.A. Sobel, L. Steinman, and S.S. Zamvil. 2007. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nature Medicine 13 (8): 935–943.CrossRefPubMed
25.
Fu, W., W. Hu, L. Shi, J.J. Mundra, G.Z. Xiao, M.L. Dustin, and C.J. Liu. 2017. Foxo4- and Stat3-dependent IL-10 production by progranulin in regulatory T cells restrains inflammatory arthritis. The FASEB Journal 31 (4): 1354–1367.CrossRefPubMed
26.
Akitsu, A., H. Ishigame, S. Kakuta, S.H. Chung, S. Ikeda, K. Shimizu, S. Kubo, Y. Liu, M. Umemura, G. Matsuzaki, Y. Yoshikai, S. Saijo, and Y. Iwakura. 2015. IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2(+)Vgamma6(+)gammadelta T cells. Nature Communications 6: 7464.CrossRefPubMedPubMedCentral
27.
Li, J.K., L. Nie, Y.P. Zhao, Y.Q. Zhang, X. Wang, S.S. Wang, Y. Liu, H. Zhao, and L. Cheng. 2016. IL-17 mediates inflammatory reactions via p38/c-Fos and JNK/c-Jun activation in an AP-1-dependent manner in human nucleus pulposus cells. Journal of Translational Medicine 14: 77.CrossRefPubMedPubMedCentral
28.
Zhang, W., L. Nie, Y. Wang, X.P. Wang, H. Zhao, S. Dongol, S. Maharjan, and L. Cheng. 2013. CCL20 secretion from the nucleus pulposus improves the recruitment of CCR6-expressing Th17 cells to degenerated IVD tissues. PLoS One 8 (6): e66286.CrossRefPubMedPubMedCentral
29.
Cheng, L., W. Fan, B. Liu, X. Wang, and L. Nie. 2013. Th17 lymphocyte levels are higher in patients with ruptured than non-ruptured lumbar discs, and are correlated with pain intensity. Injury 44 (12): 1805–1810.CrossRefPubMed
30.
Hossein-Nezhad, A., K. Mirzaei, H. Ansar, G. Khooshechin, Z. Ahmadivand, and S.A. Keshavarz. 2012. Mutual role of PGRN/TNF-alpha on osteopenia developing in obesity’s inflammation state. Minerva Medica 103 (3): 165–175.PubMed
31.
Wu, X., Y. Liu, X. Guo, W. Zhou, L. Wang, J. Shi, Y. Tao, M. Zhu, D. Geng, H. Yang, and H. Mao. 2018. Prolactin inhibits the progression of intervertebral disc degeneration through inactivation of the NF-kappaB pathway in rats. Cell Death & Disease 9 (2): 98.CrossRef
32.
Wei, J., B. Richbourgh, T. Jia, and C. Liu. 2014. ADAMTS-12: A multifaced metalloproteinase in arthritis and inflammation. Mediators of Inflammation 2014: 649718.PubMedPubMedCentral
33.
Molinos, M., C.R. Almeida, J. Caldeira, C. Cunha, R.M. Gonçalves, and M.A. Barbosa. 2015. Inflammation in intervertebral disc degeneration and regeneration. Journal of the Royal Society, Interface 12 (108): 20150429.CrossRefPubMedPubMedCentral
34.
Wang, J., D. Markova, D.G. Anderson, Z. Zheng, I.M. Shapiro, and M.V. Risbud. 2011. TNF-alpha and IL-1beta promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc. The Journal of Biological Chemistry 286 (46): 39738–39749.CrossRefPubMedPubMedCentral
35.
Purmessur, D., B.A. Walter, P.J. Roughley, D.M. Laudier, A.C. Hecht, and J. Iatridis. 2013. A role for TNFalpha in intervertebral disc degeneration: A non-recoverable catabolic shift. Biochemical and Biophysical Research Communications 433 (1): 151–156.CrossRefPubMedPubMedCentral
36.
Dudek, M., N. Yang, J.P.D. Ruckshanthi, J. Williams, E. Borysiewicz, P. Wang, A. Adamson, J. Li, J.F. Bateman, M.R. White, R.P. Boot-Handford, J.A. Hoyland, and Q.J. Meng. 2017. The intervertebral disc contains intrinsic circadian clocks that are regulated by age and cytokines and linked to degeneration. Annals of the Rheumatic Diseases 76 (3): 576–584.CrossRefPubMedPubMedCentral
37.
Zhao, Y.P., B. Liu, Q.Y. Tian, J.L. Wei, B. Richbourgh, and C.J. Liu. 2015. Progranulin protects against osteoarthritis through interacting with TNF-alpha and beta-catenin signalling. Annals of the Rheumatic Diseases 74 (12): 2244–2253.CrossRefPubMed
38.
Jian, J., G. Li, A. Hettinghouse, and C. Liu. 2018. Progranulin: A key player in autoimmune diseases. Cytokine 101: 48–55.CrossRefPubMed
39.
Zhao, Y.P., J.L. Wei, Q.Y. Tian, A.T. Liu, Y.S. Yi, T.A. Einhorn, and C.J. Liu. 2016. Progranulin suppresses titanium particle induced inflammatory osteolysis by targeting TNFalpha signaling. Scientific Reports 6: 20909.CrossRefPubMedPubMedCentral
40.
Ding, H., J. Wei, Y. Zhao, Y. Liu, L. Liu, and L. Cheng. 2017. Progranulin derived engineered protein Atsttrin suppresses TNF-alpha-mediated inflammation in intervertebral disc degenerative disease. Oncotarget 8 (65): 109692–109702.CrossRefPubMedPubMedCentral
41.
Tian, Q., et al. 2014. Three TNFR-binding domains of PGRN act independently in inhibition of TNF-alpha binding and activity. Frontiers in Bioscience (Landmark Edition) 19: 1176–1185.CrossRef
42.
Zhao, Y.P., Q.Y. Tian, B. Liu, J. Cuellar, B. Richbourgh, T.H. Jia, and C.J. Liu. 2015. Progranulin knockout accelerates intervertebral disc degeneration in aging mice. Scientific Reports 5: 9102.CrossRefPubMedPubMedCentral
43.
Matsubara, T., A. Mita, K. Minami, T. Hosooka, S. Kitazawa, K. Takahashi, Y. Tamori, N. Yokoi, M. Watanabe, E.I. Matsuo, O. Nishimura, and S. Seino. 2012. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue. Cell Metabolism 15 (1): 38–50.CrossRefPubMed
44.
Zhao, Y.P., Q.Y. Tian, and C.J. Liu. 2013. Progranulin deficiency exaggerates, whereas progranulin-derived Atsttrin attenuates, severity of dermatitis in mice. FEBS Letters 587 (12): 1805–1810.CrossRefPubMedPubMedCentral
45.
Higuchi, Y., C. McTiernan, C.B. Frye, B. McGowan, T.O. Chan, and A.M. Feldman. 2004. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy. Circulation 109 (15): 1892–1897.CrossRefPubMed
46.
Wei, J.L., W. Fu, Y.J. Ding, A. Hettinghouse, M. Lendhey, R. Schwarzkopf, O.D. Kennedy, and C.J. Liu. 2017. Progranulin derivative Atsttrin protects against early osteoarthritis in mouse and rat models. Arthritis Research & Therapy 19 (1): 280.CrossRef
47.
Zhang, Y., L. Liu, S. Wang, Y. Zhao, Y. Liu, J. Li, L. Nie, and L. Cheng. 2016. Production of CCL20 on nucleus pulposus cells recruits IL-17-producing cells to degenerated IVD tissues in rat models. Journal of Molecular Histology 47 (1): 81–89.CrossRefPubMed
48.
Wei, J., A. Hettinghouse, and C. Liu. 2016. The role of progranulin in arthritis. Annals of the New York Academy of Sciences 1383 (1): 5–20.CrossRefPubMed
Metadaten
Titel
Progranulin Is Positively Associated with Intervertebral Disc Degeneration by Interaction with IL-10 and IL-17 Through TNF Pathways
verfasst von
Shaoyi Wang
Jianlu Wei
Yuchen Fan
Hong Ding
Huichao Tian
Xiaocong Zhou
Lei Cheng
Publikationsdatum
11.07.2018
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 5/2018
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0828-1

Weitere Artikel der Ausgabe 5/2018

Inflammation 5/2018 Zur Ausgabe

ORIGINAL ARTICLE

p38 Inhibition Ameliorates Inspiratory Resistive Breathing-Induced Pulmonary Inflammation

ORIGINAL ARTICLE

Combination Therapy with Curcumin Alone Plus Piperine Ameliorates Ovalbumin-Induced Chronic Asthma in Mice

ORIGINAL ARTICLE

Curcumin Attenuates Airway Inflammation and Airway Remolding by Inhibiting NF-κB Signaling and COX-2 in Cigarette Smoke-Induced COPD Mice

ORIGINAL ARTICLE

Anti-inflammatory Effect of Somatostatin Analogue Octreotide on Rheumatoid Arthritis Synoviocytes

ORIGINAL ARTICLE

Luteoloside Protects the Uterus from Staphylococcus aureus-Induced Inflammation, Apoptosis, and Injury

REVIEW

Mechanisms of Hemolysis During Sepsis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise